Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
News-Medical.Net on MSN
CRISPR-based Cellgorithm technology ushers in a new era of cell programming
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Chinese giant Tencent's chief Sun Zhonghuai says generative AI will make up to 30% of long-form film and animation content ...
For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback